These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9379836)

  • 81. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review.
    Lindefors N
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Nov; 17(6):887-903. PubMed ID: 8278600
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Quantitation of the levels of tyrosine hydroxylase and preproenkephalin mRNAs in nigrostriatal sites after 6-hydroxydopamine lesions.
    Zhu YS; Jones SB; Burke RE; Franklin SO; Inturrisi CE
    Life Sci; 1993; 52(19):1577-84. PubMed ID: 8097862
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Changes in the mitochondrial enzyme activity in striatal projection areas after unilateral excitotoxic striatal lesions: partial restoration by embryonic striatal transplants.
    Nakao N; Nakai K; Itakura T
    Exp Neurol; 1998 Oct; 153(2):268-76. PubMed ID: 9784286
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat.
    Mercugliano M; Soghomonian JJ; Qin Y; Nguyen HQ; Feldblum S; Erlander MG; Tobin AJ; Chesselet MF
    J Comp Neurol; 1992 Apr; 318(3):245-54. PubMed ID: 1583162
    [TBL] [Abstract][Full Text] [Related]  

  • 85. GABA interneurons in the rat medial frontal cortex: characterization by quantitative in situ hybridization of the glutamic acid decarboxylase (GAD67) mRNA.
    Retaux S; Caboche J; Rogard M; Julien JF; Penit-Soria J; Besson MJ
    Brain Res; 1993 May; 611(2):187-96. PubMed ID: 8334513
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model.
    Nikkhah G; Cunningham MG; Jödicke A; Knappe U; Björklund A
    Brain Res; 1994 Jan; 633(1-2):133-43. PubMed ID: 7907929
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Functional activity of substantia nigra grafts reinnervating the striatum: neurotransmitter metabolism and [14C]2-deoxy-D-glucose autoradiography.
    Schmidt RH; Ingvar M; Lindvall O; Stenevi U; Björklund A
    J Neurochem; 1982 Mar; 38(3):737-48. PubMed ID: 6120214
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate.
    Castañeda E; Fleming S; Paquette MA; Boat K; Moffett J; Stachowiak EK; Bloom DC; Stachowiak MK
    Physiol Behav; 2005 Mar; 84(4):525-35. PubMed ID: 15811387
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Intralaminar thalamic nuclei lesions: widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia.
    Bacci JJ; Kachidian P; Kerkerian-Le Goff L; Salin P
    J Neuropathol Exp Neurol; 2004 Jan; 63(1):20-31. PubMed ID: 14748558
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts.
    Rosenblad C; Martinez-Serrano A; Björklund A
    Neuroscience; 1996 Dec; 75(4):979-85. PubMed ID: 8938733
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S; Levivier M; Jiang H; Ferreira M; Jackson-Lewis V; Donaldson D; Togasaki DM
    Neuroscience; 1995 Aug; 67(3):631-47. PubMed ID: 7675192
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The functional impact of the intrastriatal dopamine neuron grafts in parkinsonian rats is reduced with advancing disease.
    Breysse N; Carlsson T; Winkler C; Björklund A; Kirik D
    J Neurosci; 2007 May; 27(22):5849-56. PubMed ID: 17537955
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TH protein and mRNA in nigrostriatal dopaminergic neurons are down-regulated by continuous but not intermittent apomorphine.
    Iwata S; Nomoto M; Kaseda S; Tanoue S; Shimosaka M; Fukuda T
    Brain Res Mol Brain Res; 2000 Oct; 82(1-2):133-6. PubMed ID: 11042366
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of nigral and striatal grafts on skilled forelimb use in the rat.
    Montoya CP; Astell S; Dunnett SB
    Prog Brain Res; 1990; 82():459-66. PubMed ID: 2127111
    [No Abstract]   [Full Text] [Related]  

  • 95. Behavioural effects of intracerebral dopaminergic grafts after neonatal destruction of the mesencephalic dopaminergic system.
    Abrous N; Choulli K; Simon H; Le Moal M; Herman JP
    Prog Brain Res; 1990; 82():481-7. PubMed ID: 2127114
    [No Abstract]   [Full Text] [Related]  

  • 96. A functional assessment of embryonic dopaminergic grafts in the marmoset.
    Annett LE; Dunnett SB; Martel FL; Rogers DC; Ridley RM; Baker HF; Marsden CD
    Prog Brain Res; 1990; 82():535-42. PubMed ID: 2127119
    [No Abstract]   [Full Text] [Related]  

  • 97. Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations.
    Díaz MR; Barroso-Chinea P; Acevedo A; González-Hernández T
    Mov Disord; 2003 Mar; 18(3):254-266. PubMed ID: 12621628
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Optimal effectiveness of BDNF for fetal nigral transplants coincides with the ontogenic appearance of BDNF in the striatum.
    Yurek DM; Hipkens SB; Wiegand SJ; Altar CA
    J Neurosci; 1998 Aug; 18(15):6040-7. PubMed ID: 9671688
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Developmental regulation of glutamic acid decarboxylase mRNA expression and splicing in the rat striatum by dopamine.
    Küppers E; Sabolek M; Anders U; Pilgrim C; Beyer C
    Brain Res Mol Brain Res; 2000 Sep; 81(1-2):19-28. PubMed ID: 11000475
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Possible mechanisms of action of adrenal transplants in Parkinson's disease.
    Drucker-Colín R; García-Hernández F; Mendoza-Ramírez JL; Pacheco-Cano MT; Komisaruk BR
    Prog Brain Res; 1990; 82():509-14. PubMed ID: 1963226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.